Publications

5530 Results

Activity of fludarabine monophosphate in patients with Lymphoma advanced mycosis fungoides: A Southwest Oncology Group study.

Authors
DD Von Hoff;S Dahlberg;RJ Hartsock;HJ Eyre
Journal / Conference
JNCI 82:1353-1354
Year
1990
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8323

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.

Authors
DD Von Hoff;S Green;EA Surwit;EV Hannigan;DS Alberts
Journal / Conference
JCO 13(5):433-435
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8328

Phase II trial of intravenous melphalan for metastatic colorectal carcinoma: A Southwest Oncology Group study.

Authors
WA Knight III;P Goodman;SA Taylor;JS Macdonald;C Coltman, Jr;JJ Costanzi;LH Baker
Journal / Conference
Invest New Drugs 8:S87-S89
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8373

Phase II evaluation of esorubicin (4' deoxydoxorubicin) in pancreatic adenocarcinoma. A Southwest Oncology Group study.

Authors
CB Vaughn;SE Salmon;TR Fleming
Journal / Conference
Invest New Drugs 8:81-85
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8404

Carboplatin therapy in advanced endometrial cancer. A Southwest Oncology Group study.

Authors
JB Green;S Green;DS Alberts;R O'Toole;EA Surwit;JW Noltimier
Journal / Conference
Obst and Gyn 75(4):696-700
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8407

Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.

Authors
EH Kraut;JJ Crowley;MR Grever;MD Keppen;JD Bonnet;HE Hynes;SE Salmon
Journal / Conference
IND 8:199-200
Year
1990
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8409

M-BACOD treatment for intermediate and high grade malignant lymphomas: A Southwest Oncology Group phase II trial.

Authors
BW Dana;S Dahlberg;TP Miller;Hartsock;S Balcerzak;C Coltman, Jr;JO Carden;K Hartley;RI Fisher
Journal / Conference
JCO 8(7):1155-1162
Year
1990
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410

Improved efficacy of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Preliminary report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV suboptimal ovarian cancer.

Authors
DS Alberts;SJ Green;EV Hannigan;R O'Toole;N Mason-Liddil;EA Surwit;D Stock-Novack;R Goldberg;VK Malviya;WA Nahhas;RP Pugh;JT Guy;SR Dakhil
Journal / Conference
Carboplatin Current Perspectives and Future Directions (JM-8):163-164
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

VM-26 in colorectal carcinoma: A Southwest Oncology Group study.

Authors
N Oishi;TR Fleming;L Laufman;JS Ungerleider;RB Natale;AB Einstein;DD Von Hoff;JS Macdonald
Journal / Conference
Invest New Drugs 8:93-95
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8426

High-dose cisplatin for metastatic soft tissue sarcoma. A Southwest Oncology Group study.

Authors
GT Budd;B Metch;SP Balcerzak;WS Fletcher;LH Baker;JE Mortimer
Journal / Conference
Cancer 65:866-869
Year
1990
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8465